drugset / Trial / NCT00932737
(Hyoscine Butylbromide) for Abdominal Pain Associated With Cramping on Demand Basis
RandomizedParallel-groupDouble-blindTreatment
Summary
The primary objective of this pilot study is to assess effects of Hyoscine Butylbromide (HBB) 20 mg in comparison to placebo, when used as needed, as measured by the subject's assessment of intensity of abdominal pain associated with cramping (APC) in the treatment of two episodes.
Timeline
- Start
- 2009-06-09
- Primary completion
- 2010-02-08
- Completion
- 2010-02-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Hyoscine butylbromide | Unknown | 20 mg | — |
Indications
No indication recorded.